Verrica Pharmaceuticals (VRCA) Revenue & Revenue Breakdown
Verrica Pharmaceuticals Revenue Highlights
Latest Revenue (Y)
$5.12M
Latest Revenue (Q)
$3.83M
Main Segment (Y)
Product
Verrica Pharmaceuticals Revenue by Period
Verrica Pharmaceuticals Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $5.12M | -43.27% |
| 2022-12-31 | $9.03M | -24.73% |
| 2021-12-31 | $12.00M | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2017-12-31 | - | 100.00% |
| 2016-12-31 | - | - |
Verrica Pharmaceuticals generated $5.12M in revenue during NA 2023, up -43.27% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
Verrica Pharmaceuticals Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-03-31 | $3.83M | 92.45% |
| 2023-12-31 | $1.99M | -31.85% |
| 2023-09-30 | $2.92M | 1502.75% |
| 2023-06-30 | $182.00K | 391.89% |
| 2023-03-31 | $37.00K | -45.59% |
| 2022-12-31 | $68.00K | -99.18% |
| 2022-09-30 | $8.32M | 3787.38% |
| 2022-06-30 | $214.00K | -50.35% |
| 2022-03-31 | $431.00K | -103.59% |
| 2021-12-31 | $-12.00M | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | -100.00% |
| 2021-03-31 | $12.00M | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2019-09-30 | - | 100.00% |
| 2019-06-30 | - | 100.00% |
| 2019-03-31 | - | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2018-09-30 | - | 100.00% |
| 2018-06-30 | - | 100.00% |
| 2018-03-31 | - | 100.00% |
| 2017-12-31 | - | 100.00% |
| 2017-09-30 | - | 100.00% |
| 2017-06-30 | - | 100.00% |
| 2017-03-31 | - | - |
Verrica Pharmaceuticals generated $3.83M in revenue during Q1 2024, up 92.45% compared to the previous quarter, and up 5626.47% compared to the same period a year ago.
Verrica Pharmaceuticals Revenue Breakdown
Verrica Pharmaceuticals Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 23 |
|---|---|
| Collaboration | $466.00K |
| Product | $4.66M |
Verrica Pharmaceuticals's latest annual revenue breakdown by segment (product or service), as of Dec 23: Product (90.91%), and Collaboration (9.09%).
Quarterly Revenue by Product
| Product/Service | Jun 24 | Mar 24 |
|---|---|---|
| Collaboration | $285.00K | $594.00K |
| Product | $4.89M | $3.23M |
Verrica Pharmaceuticals's latest quarterly revenue breakdown by segment (product or service), as of Jun 24: Product (94.49%), and Collaboration (5.51%).
Verrica Pharmaceuticals Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| ASND | Ascendis Pharma | $266.72M | $95.89M |
| ARQT | Arcutis Biotherapeutics | $59.61M | $30.86M |
| ETON | Eton Pharmaceuticals | $31.64M | $9.07M |
| FENC | Fennec Pharmaceuticals | $21.64M | $25.26M |
| IVA | Inventiva | $17.50M | $15.58M |
| KDNY | Chinook Therapeutics | $6.13M | $1.01M |
| VRCA | Verrica Pharmaceuticals | $5.12M | $3.83M |
| CRNX | Crinetics Pharmaceuticals | $4.01M | $640.00K |
| PLRX | Pliant Therapeutics | $1.58M | - |
| FIXX | Q32 Bio | $1.16M | - |
| LIAN | LianBio | - | - |
| CNTB | Connect Biopharma | - | - |
| DICE | DICE Therapeutics | - | - |
| ABOS | Acumen Pharmaceuticals | - | - |
| VRNA | Verona Pharma | - | - |
| GRTX | Galera Therapeutics | - | - |
| LRMR | Larimar Therapeutics | - | - |
| VIGL | Vigil Neuroscience | - | - |
| EWTX | Edgewise Therapeutics | - | - |
| NUVB | Nuvation Bio | - | $1.44M |
| ELDN | Eledon Pharmaceuticals | - | - |
VRCA Revenue FAQ
What is Verrica Pharmaceuticals’s yearly revenue?
Verrica Pharmaceuticals's yearly revenue for 2023 was $5.12M, representing a decrease of -43.27% compared to 2022. The company's yearly revenue for 2022 was $9.03M, representing a decrease of -24.73% compared to 2021. VRCA's yearly revenue for 2021 was $12M, representing an increase of 100.00% compared to 2020.
What is Verrica Pharmaceuticals’s quarterly revenue?
Verrica Pharmaceuticals's quarterly revenue for Q1 2024 was $3.83M, a 92.45% increase from the previous quarter (Q4 2023), and a 10240.54% increase year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $1.99M, a -31.85% decrease from the previous quarter (Q3 2023), and a 2823.53% increase year-over-year (Q4 2022). VRCA's quarterly revenue for Q3 2023 was $2.92M, a 1502.75% increase from the previous quarter (Q2 2023), and a -64.94% decrease year-over-year (Q3 2022).
What is Verrica Pharmaceuticals’s revenue growth rate?
Verrica Pharmaceuticals's revenue growth rate for the last 3 years (2021-2023) was -57.30%, and for the last 5 years (2019-2023) was 0%.
What are Verrica Pharmaceuticals’s revenue streams?
Verrica Pharmaceuticals's revenue streams in c 23 are Collaboration, and Product. Collaboration generated $466K in revenue, accounting 9.09% of the company's total revenue Product generated $4.66M in revenue, accounting 90.91% of the company's total revenue
What is Verrica Pharmaceuticals’s main source of revenue?
For the fiscal year ending Dec 23, the largest source of revenue of Verrica Pharmaceuticals was Product. This segment made a revenue of $4.66M, representing 90.91% of the company's total revenue.